Anika Therapeutics | Pre Utilidad Fiscal

Precio De Mercado
14.18
Cambio Diario
-0.14 -0.98%
Mensual
32.90%
Anual
-15.90%
Q1 Expectativa
13.92




Pre Utilidad Fiscal Cambio Fecha
Abbott USD 2.36B 178M 2025-12
Agenus USD -274.14M 80.46M 2025-09
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Anika Therapeutics USD -3.87M 32.43M 2025-03
Arrowhead Research USD 28.27M 7.85M 2025-12
Enanta Pharmaceuticals USD -22.71M 95.08M 2024-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -326.93M 41.77M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intrexon USD -60.48M 27.09M 2024-06
J&J USD 4.97B 2.53B 2025-12
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Smith & Nephew USD 469M 70M 2025-12
Stryker USD 1.03B 13M 2025-09
Surmodics USD -7.51M 1.69M 2024-09
Veracyte USD 40.63M 21.74M 2025-12
Xencor USD -4.27M 1.76M 2025-12
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09


Anika Therapeutics Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.